Lifecore Biomedical, Inc. De (LFCR) Operating Leases (2019 - 2025)

Lifecore Biomedical's Operating Leases history runs 7 years deep, the most recent figure standing at $5.4 million for Q1 2025.

• In Q1 2025, Operating Leases rose 6.17% year-over-year to $5.4 million; the TTM figure through Feb 2025 stood at $5.4 million (up 6.17% YoY), while the FY2024 annual figure was $1.7 million, down 82.19% from the prior year.
• Operating Leases was $5.4 million for Q1 2025 at Lifecore Biomedical, down from $7.4 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $17.9 million in Q1 2021 to a low of $1.7 million in Q2 2024.
• Historically, Operating Leases has averaged $8.9 million across 5 years, with a median of $7.8 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Operating Leases jumped 32.96% in 2023, then tumbled 82.19% in 2024.
• A 5-year view of Operating Leases shows it stood at $11.3 million in 2021, then slumped by 38.12% to $7.0 million in 2022, then jumped by 32.96% to $9.3 million in 2023, then decreased by 20.47% to $7.4 million in 2024, then slipped by 27.23% to $5.4 million in 2025.
• The last three Operating Leases figures came in at $5.4 million (Q1 2025), $7.4 million (Q4 2024), and $4.8 million (Q3 2024), per Business Quant data.